NASDAQ
Amphastar Pharmaceuticals, Inc. (AMPH) reported revenue of $719.89M and net income of $98.09M for FY 2025. The gross profit margin is 49.5% with a net profit margin of 13.6%.
Financial data for AMPH
1.65% YoY
38.51% YoY
36.17% YoY
Annual Income Statement for AMPH
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $720M | $732M | $644M | $499M | $438M |
| Cost of Revenue | $364M | $358M | $293M | $250M | $238M |
| Gross Profit | $356M | $374M | $351M | $249M | $200M |
| Operating Expenses | $216M | $168M | $154M | $141M | $130M |
| Operating Income | $140M | $205M | $197M | $107M | $70M |
| Net Income | $98M | $160M | $138M | $91M | $62M |
| EPS | $2.10 | $3.29 | $2.85 | $1.88 | $1.30 |
| EBITDA | $149M | $277M | $240M | $146M | $112M |
No price data available for this timeframe.